pipeline   autoimmune/inflammation  |  oncology

Alpine’s pipeline

A Phase 1 healthy volunteer study for ALPN-101 completed enrollment in October 2019. Initial data were presented at the 2019 American Society of Hematology annual meeting and additional data from this trial will be presented in 2020. ‘BALANCE’, a Phase 1b/2 trial in acute graft versus host disease (GVHD) is projected to begin enrolling in 2020.  ALPN-202 is intended to begin enrolling a Phase 1 trial in cancer patients in 2020.